- Service Name
CellGenTech Gene Therapy and Regenerative Medicine
- Industry
Biotechnology, Therapeutics, Gene Therapy, Regenerative Medicine
- Main Value Proposition
CellGenTech offers cutting-edge gene therapy solutions that leverage the unique properties of human adipose cells to address unmet medical needs in rare diseases.
- Description
CellGenTech specializes in the development of innovative gene therapies and regenerative medicine products aimed at treating rare diseases. Their focus is on utilizing human adipose-derived cells for advanced therapeutic applications.
- Key Features
Ex-vivo gene therapy platform using human adipose cells; Focus on rare diseases treatment; Collaboration with leading research institutions; Innovative clinical research and development
- Use Cases
Treatment of familial LCAT deficiency; Development of therapies for hemophilia A; Innovative solutions for Fabry disease
- Competitive advantages
Strong partnerships with academic institutions like Chiba University; Proven track record in clinical research and development; Focus on personalized medicine through the use of patients' own cells
- Strengths
CellGenTech's main strengths include its innovative approach to gene therapy, strong research collaborations, and a commitment to addressing rare diseases with high unmet needs.
- Positioning
CellGenTech positions itself as a leader in the field of gene therapy and regenerative medicine, focusing on innovative solutions for rare diseases.
- Audience
The primary target users include healthcare professionals, researchers in gene therapy, and patients suffering from rare genetic disorders.
- CTA
Contact us for more information
- Tags
Gene Therapy
Regenerative Medicine
Rare Diseases
Adipose Cells
- Tagline
Aiming for the development of new gene therapy and regenerative medicine products.
- Tone of Voice
Innovative, professional, compassionate
- Differentiation
CellGenTech stands out in the market by being one of the pioneers in utilizing human adipose-derived cells for gene therapy, specifically targeting rare genetic disorders.
- Brand Positioning
The brand is identified as a forward-thinking therapeutics company dedicated to advancing medical science through innovative gene therapies.
- Founded
2003-10-20
- Founders
Masayuki Aso